These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11416620)

  • 1. Nonsustained Ventricular Tachycardia as a Predictor of Cardiovascular Events in Black Men With Hypertensive Left Ventricular Hypertrophy.
    Greenberg MD; Papademetriou V; Narayan P; Kokkinos P
    J Clin Hypertens (Greenwich); 2000 Jan; 2(1):14-19. PubMed ID: 11416620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of ventricular arrhythmia in hypertensive patients].
    Galinier M; Balanescu S; Fourcade J; Dorobantu M; Massabuau P; Dongay B; Cabrol P; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1049-53. PubMed ID: 9404407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
    Li Z; Dahlöf B; Okin PM; Kjeldsen SE; Wachtell K; Ibsen H; Nieminen MS; Jern S; Devereux RB
    J Hypertens; 2008 Jun; 26(6):1244-9. PubMed ID: 18475164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy.
    McLenachan JM; Henderson E; Morris KI; Dargie HJ
    N Engl J Med; 1987 Sep; 317(13):787-92. PubMed ID: 2957590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate as independent prognostic factor for mortality in normotensive hemodialysed patients.
    Cice G; Di Benedetto A; D'Andrea A; D'Isa S; De Gregorio P; Marcelli D; Gatti E; Calabrò R
    J Nephrol; 2008; 21(5):704-12. PubMed ID: 18949725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial.
    Zimetbaum PJ; Buxton AE; Batsford W; Fisher JD; Hafley GE; Lee KL; O'Toole MF; Page RL; Reynolds M; Josephson ME
    Circulation; 2004 Aug; 110(7):766-9. PubMed ID: 15289365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey.
    Paoletti E; Specchia C; Di Maio G; Bellino D; Damasio B; Cassottana P; Cannella G
    Nephrol Dial Transplant; 2004 Jul; 19(7):1829-34. PubMed ID: 15128888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of left ventricular hypertrophy on early and long-term survival after coronary artery bypass grafting.
    Toumpoulis IK; Chamogeorgakis TP; Angouras DC; Swistel DG; Anagnostopoulos CE; Rokkas CK
    Int J Cardiol; 2009 Jun; 135(1):36-42. PubMed ID: 18579225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of prolonged ventricular repolarization in hypertension.
    Schillaci G; Pirro M; Ronti T; Gemelli F; Pucci G; Innocente S; Porcellati C; Mannarino E
    Arch Intern Med; 2006 Apr; 166(8):909-13. PubMed ID: 16636218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of cardiac events in patients with isolated syncope and negative electrophysiologic study.
    Da Costa A; Gulian JL; Romeyer-Bouchard C; Messier M; Zarqane N; Samuel B; Khiel A; Isaaz K
    Int J Cardiol; 2006 Apr; 109(1):28-33. PubMed ID: 15975670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications.
    Colivicchi F; Mettimano M; Genovesi-Ebert A; Schinzari F; Iantorno M; Melina G; Santini M; Cardillo C; Melina D
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):267-72. PubMed ID: 18301144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
    Olsen MH; Wachtell K; Ibsen H; Lindholm LH; Dahlöf B; Devereux RB; Kjeldsen SE; Oikarinen L; Okin PM;
    J Hypertens; 2006 Apr; 24(4):775-81. PubMed ID: 16531808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
    Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
    Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.